SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Piper Jaffray Maintains Overweight on Globus Medical, Raises Price Target to $65

Piper Jaffray maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $62 to $65.

Benzinga · -

Piper Jaffray maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $62 to $65.